Viewing Study NCT00490243



Ignite Creation Date: 2024-05-05 @ 6:31 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00490243
Status: COMPLETED
Last Update Posted: 2007-06-28
First Post: 2007-06-21

Brief Title: Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma
Sponsor: Medical University of Lodz
Organization: Medical University of Lodz

Study Overview

Official Title: A Randomized Double-Blind Trial of the Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma
Status: COMPLETED
Status Verified Date: 2007-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The present study was conducted to determine the effects of four week treatment with budesonide montelukast budesonide with montelukast and budesonide with formoterol in children with atopic asthma on lung function forced expiratory volume in one second mid-expiratory flow peak expiratory flow rate resistance by the interrupter technique plethysmographic specific airway resistance exercise-induced bronchial hyperreactivity and clinical symptoms
Detailed Description: Asthma is one of the most common chronic disease worldwide imposing a substantial social burden on children Allergic inflammation is responsible for all clinical symptoms of asthma The effects of allergic inflammation are bronchial muscle constriction excessive mucus production and edema of mucosa all elements of asthmatic triad causing bronchial obturation Normal lung function is one of the goals of asthma management In most of the studies the effect of monotherapy on the symptom scores lung function parameters and bronchial hyperreactivity was assessed

The present study was conducted to determine the effects of four week treatment with budesonide montelukast budesonide with montelukast and budesonide with formoterol in children with atopic asthma on lung function forced expiratory volume in one second mid-expiratory flow peak expiratory flow rate resistance by the interrupter technique plethysmographic specific airway resistance exercise-induced bronchial hyperreactivity and clinical symptoms

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None